BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 16115812)

  • 21. [Huntington disease. A review].
    Bonilla E
    Invest Clin; 2000 Jun; 41(2):117-41. PubMed ID: 10961047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A patient-derived cellular model for Huntington's disease reveals phenotypes at clinically relevant CAG lengths.
    Hung CL; Maiuri T; Bowie LE; Gotesman R; Son S; Falcone M; Giordano JV; Gillis T; Mattis V; Lau T; Kwan V; Wheeler V; Schertzer J; Singh K; Truant R
    Mol Biol Cell; 2018 Nov; 29(23):2809-2820. PubMed ID: 30256717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neocortical neurons cultured from mice with expanded CAG repeats in the huntingtin gene: unaltered vulnerability to excitotoxins and other insults.
    Snider BJ; Moss JL; Revilla FJ; Lee CS; Wheeler VC; Macdonald ME; Choi DW
    Neuroscience; 2003; 120(3):617-25. PubMed ID: 12895502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of huntingtin promotes neural stem cells differentiation into glial cells while neurons expressing huntingtin with expanded polyglutamine tracts undergo cell death.
    Conforti P; Camnasio S; Mutti C; Valenza M; Thompson M; Fossale E; Zeitlin S; MacDonald ME; Zuccato C; Cattaneo E
    Neurobiol Dis; 2013 Feb; 50():160-70. PubMed ID: 23089356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Energy Metabolism and Mitochondrial Superoxide Anion Production in Pre-symptomatic Striatal Neurons Derived from Human-Induced Pluripotent Stem Cells Expressing Mutant Huntingtin.
    Hamilton J; Brustovetsky T; Sridhar A; Pan Y; Cummins TR; Meyer JS; Brustovetsky N
    Mol Neurobiol; 2020 Feb; 57(2):668-684. PubMed ID: 31435904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease.
    Wyttenbach A; Swartz J; Kita H; Thykjaer T; Carmichael J; Bradley J; Brown R; Maxwell M; Schapira A; Orntoft TF; Kato K; Rubinsztein DC
    Hum Mol Genet; 2001 Aug; 10(17):1829-45. PubMed ID: 11532992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in N-methyl-D-aspartate receptor sensitivity and magnesium blockade occur early in development in the R6/2 mouse model of Huntington's disease.
    Starling AJ; André VM; Cepeda C; de Lima M; Chandler SH; Levine MS
    J Neurosci Res; 2005 Nov; 82(3):377-86. PubMed ID: 16211559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dramatic mutation instability in HD mouse striatum: does polyglutamine load contribute to cell-specific vulnerability in Huntington's disease?
    Kennedy L; Shelbourne PF
    Hum Mol Genet; 2000 Oct; 9(17):2539-44. PubMed ID: 11030759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dominant effects of the Huntington's disease HTT CAG repeat length are captured in gene-expression data sets by a continuous analysis mathematical modeling strategy.
    Lee JM; Galkina EI; Levantovsky RM; Fossale E; Anne Anderson M; Gillis T; Srinidhi Mysore J; Coser KR; Shioda T; Zhang B; Furia MD; Derry J; Kohane IS; Seong IS; Wheeler VC; Gusella JF; MacDonald ME
    Hum Mol Genet; 2013 Aug; 22(16):3227-38. PubMed ID: 23595883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triplet repeat mutation length gains correlate with cell-type specific vulnerability in Huntington disease brain.
    Shelbourne PF; Keller-McGandy C; Bi WL; Yoon SR; Dubeau L; Veitch NJ; Vonsattel JP; Wexler NS; ; Arnheim N; Augood SJ
    Hum Mol Genet; 2007 May; 16(10):1133-42. PubMed ID: 17409200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Weight loss in Huntington disease increases with higher CAG repeat number.
    Aziz NA; van der Burg JM; Landwehrmeyer GB; Brundin P; Stijnen T; ; Roos RA
    Neurology; 2008 Nov; 71(19):1506-13. PubMed ID: 18981372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ca2+-induced permeability transition in human lymphoblastoid cell mitochondria from normal and Huntington's disease individuals.
    Panov AV; Lund S; Greenamyre JT
    Mol Cell Biochem; 2005 Jan; 269(1-2):143-52. PubMed ID: 15786727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical correlates of mitochondrial function in Huntington's disease muscle.
    Turner C; Cooper JM; Schapira AH
    Mov Disord; 2007 Sep; 22(12):1715-21. PubMed ID: 17557337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective neuronal degeneration in Huntington's disease.
    Cowan CM; Raymond LA
    Curr Top Dev Biol; 2006; 75():25-71. PubMed ID: 16984809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6/2 mice.
    Morton AJ; Glynn D; Leavens W; Zheng Z; Faull RL; Skepper JN; Wight JM
    Neurobiol Dis; 2009 Mar; 33(3):331-41. PubMed ID: 19130884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nucleocytoplasmic trafficking and transcription effects of huntingtin in Huntington's disease.
    Truant R; Atwal RS; Burtnik A
    Prog Neurobiol; 2007 Nov; 83(4):211-27. PubMed ID: 17240517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-dependent changes in the calcium sensitivity of striatal mitochondria in mouse models of Huntington's Disease.
    Brustovetsky N; LaFrance R; Purl KJ; Brustovetsky T; Keene CD; Low WC; Dubinsky JM
    J Neurochem; 2005 Jun; 93(6):1361-70. PubMed ID: 15935052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uninterrupted CAG repeat drives striatum-selective transcriptionopathy and nuclear pathogenesis in human Huntingtin BAC mice.
    Gu X; Richman J; Langfelder P; Wang N; Zhang S; Bañez-Coronel M; Wang HB; Yang L; Ramanathan L; Deng L; Park CS; Choi CR; Cantle JP; Gao F; Gray M; Coppola G; Bates GP; Ranum LPW; Horvath S; Colwell CS; Yang XW
    Neuron; 2022 Apr; 110(7):1173-1192.e7. PubMed ID: 35114102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of triplet repeats in the huntingtin gene in Japanese families affected with Huntington's disease.
    Masuda N; Goto J; Murayama N; Watanabe M; Kondo I; Kanazawa I
    J Med Genet; 1995 Sep; 32(9):701-5. PubMed ID: 8544189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release.
    Jana NR; Zemskov EA; Wang Gh ; Nukina N
    Hum Mol Genet; 2001 May; 10(10):1049-59. PubMed ID: 11331615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.